Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × belinostat × Clear all

Phase

Status

Completed 29 Terminated 9 Recruiting 5 Withdrawn 3 Active not recruiting 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 466 Radiotherapy 321 Carboplatin 321 Cyclophosphamide 320 Paclitaxel 296 Capecitabine 294 Oxaliplatin 286 Gemcitabine 280 Docetaxel 280 Fluorouracil 251 apatinib 226 Bevacizumab 205 Drug Therapy 203 camrelizumab 189 Etoposide 178 Irinotecan 162 Doxorubicin 157 Dexamethasone 140 Leucovorin 135 Cytarabine 129 sintilimab 119 Pemetrexed 119 anlotinib 116 toripalimab 113 pembrolizumab 112 Vincristine 109 S 1 (combination) 109 Rituximab 109 Neoadjuvant Therapy 108 fludarabine 99

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02137759 2023-05-06

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Emory University

Phase 2 Unknown

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡